Calumet gains after anticipating Q4 adjusted EBITDA of $45M-$60M (NASDAQ:CLMT)

[ad_1]

Group of rows of green stacked biofuel drums in storage warehouse

scanrail/iStock via Getty Images

Calumet (NASDAQ:CLMT) +1.9% pre-market Tuesday after providing preliminary Q4 financial results, expecting to report a net loss in the $24M-$54M range and adjusted EBITDA of $45M-$60M.

The company also forecasts FY 2025 capital spending of $50M-$70M in its specialties business and $10M-$20M of maintenance

[ad_2]

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *